Ocular Therapeutix, Inc. (OCUL)

9.65 -0.03 (-0.31%) USD  |  NASDAQ  |  May 08, 16:00
9.655 0.00 (0.00%) After-Hours: 20:00
More

Ocular Therapeutix Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
EyePoint, Inc. Upgrade
Merck & Co., Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade